In vivo cardiac diffusion tensor imaging quantifies microstructural disorganization to distinguish hypertrophic cardiomyopathy from hypertensive heart disease
The International Journal of Cardiovascular Imaging · 2026
DOI: 10.1007/s10554-026-03647-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift The International Journal of Cardiovascular Imaging, 2026. Verfasst von Yujie Liu und 17 weiteren Autor:innen. Beteiligte Einrichtung: Radiology Imaging Center, Fuwai Hospital, National Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Chinese Academ…. Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic, Diffusion Tensor Imaging, Hypertension, Myocardium. Die Arbeit nennt 31 Literaturangaben. Gefördert von: National Natural Science Foundation of China Key Project, National Key Research and Development Program of China, National Natural Science Foundation of China Project.
Abstract (Originalsprache)
OBJECTIVES: To evaluate whether cardiac diffusion tensor imaging (cDTI) can discriminate hypertrophic cardiomyopathy (HCM) from hypertensive heart disease (HHD) based on microstructural alterations. MATERIALS AND METHODS: This prospective study enrolled 40 HCM patients and 14 HHD patients who underwent 3.0T cardiac magnetic resonance (CMR), including cDTI, T1 mapping and late gadolinium enhancement (LGE). Parameters of cDTI (mean diffusivity [MD], secondary eigenvector [E2A], helix angel [HA)] and fractional anisotropy [FA]) were compared across groups using analysis of covariance. Diagnostic performance was assessed using receiver operating characteristic analysis. A subgroup analysis was performed in HCM patients with mild hypertrophy (left ventricular wall thickness [LVWT] 13-19 mm). RESULTS: Compared to patients with HHD, those with HCM showed significantly greater LVWT, LGE extent, native T1 and extracellular volume fraction (ECV, all p < 0.05). cDTI revealed significant microstructural alterations in HCM, characterized by reduced FA (p = 0.001) and elevated E2A p < 0.001). Analysis of covariance confirmed these differences after adjusting for LVWT, native T1, and ECV. ROC analysis demonstrated that E2A (AUC = 0.88) and FA (AUC = 0.79) had superior diagnostic performance for distinguishing HCM from HHD, outperforming native T1 (AUC = 0.76), ECV (AUC = 0.75), and LGE extent (AUC = 0.67). In the HCM subgroup, E2A maintained the highest diagnostic performance (AUC = 0.86), followed by FA and ECV (both AUC = 0.73). CONCLUSIONS: E2A and FA derived from cDTI were robust biomarkers of microstructural alterations, enabling superior differentiation of HCM from HHD beyond conventional hypertrophy and fibrosis indices. These findings support the potential utility of cDTI in diagnosis of ambiguous hypertrophy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Radiology Imaging Center, Fuwai Hospital, National Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beilishi Road…
- Clinical & Technical Support, Philips Healthcare, Beijing, China.
- School of Biomedical Engineering and Informatics, Nanjing Medical University, 101 Longmian Ave, Jiangning District, Nanjing, 211166, China. zkk1988105@qq.com.
Förderung
- National Natural Science Foundation of China Key Project
- National Key Research and Development Program of China
- National Natural Science Foundation of China Project
Zitieren
APA
Liu, Y., Dong, Z., Yin, G., Sun, P., Ma, X., Tang, Y., Zhou, P., Jia, X., Chen, X., Aisikaier, K., Sa, F., Xu, W., Li, B., Yang, K., Lu, M., Zhao, S., Zhao, K., & Chen, X. (2026). In vivo cardiac diffusion tensor imaging quantifies microstructural disorganization to distinguish hypertrophic cardiomyopathy from hypertensive heart disease. The International Journal of Cardiovascular Imaging. https://doi.org/10.1007/s10554-026-03647-3
Vancouver
Liu Y, Dong Z, Yin G, Sun P, Ma X, Tang Y, et al. In vivo cardiac diffusion tensor imaging quantifies microstructural disorganization to distinguish hypertrophic cardiomyopathy from hypertensive heart disease. The International Journal of Cardiovascular Imaging. 2026. doi:10.1007/s10554-026-03647-3
BibTeX
@article{Liu2026,
author = {Liu, Yujie and Dong, Zhixiang and Yin, Gang and Sun, Peng and Ma, Xuan and Tang, Yun and Zhou, Pengyu and Jia, Xi and Chen, Xingrui and Aisikaier, Kaisaierjiang and Sa, Fen and Xu, Wenqing and Li, Bo and Yang, Kai and Lu, Minjie and Zhao, Shihua and Zhao, Kankan and Chen, Xiuyu},
title = {In vivo cardiac diffusion tensor imaging quantifies microstructural disorganization to distinguish hypertrophic cardiomyopathy from hypertensive heart disease},
journal = {The International Journal of Cardiovascular Imaging},
year = {2026},
doi = {10.1007/s10554-026-03647-3}
}
EUVIMED